{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:19:45Z","timestamp":1762100385481},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T00:00:00Z","timestamp":1118361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00228-005-0947-0","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T09:42:35Z","timestamp":1118310155000},"page":"439-444","source":"Crossref","is-referenced-by-count":32,"title":["Main comedications associated with major bleeding during anticoagulant therapy with coumarins"],"prefix":"10.1007","volume":"61","author":[{"given":"Fernie","family":"Penning-van Beest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00eblle","family":"Erkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Uwe","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Rudolf","family":"Koelz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Herings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,6,10]]},"reference":[{"key":"947_CR1","first-page":"1008","volume-title":"Meyler\u2019s side effects of drugs: an encyclopedia of adverse reactions and interactions","author":"J Caron","year":"1996","unstructured":"Caron J, Libersa C, Thomas C (1996) Drugs affecting blood clotting, fibrinolysis, and hemostasis. In: Dukes MNG (ed) Meyler\u2019s side effects of drugs: an encyclopedia of adverse reactions and interactions, 13th edn. Elsevier Science, Amsterdam, pp 1008\u20131055","edition":"13"},{"issue":"6","key":"947_CR2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1524-4733.2000.36006.x","volume":"3","author":"VS Catalan","year":"2000","unstructured":"Catalan VS, LeLorier J (2000) Predictors of long-term persistence on statins in a subsidized clinical population. Value Health 3(6):417\u2013426","journal-title":"Value Health"},{"key":"947_CR3","unstructured":"Commissie Interacterende medicatie cumarines (2002) Standaard afhandeling cumarine-interacties [cited 2003 Feb 12]. Available from: URL: http:\/\/www.fnt.nl\/artsen\/index.html"},{"issue":"6","key":"947_CR4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2165\/00003088-199630060-00002","volume":"30","author":"S Harder","year":"1996","unstructured":"Harder S, Thurmann P (1996) Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet 30(6):416\u2013444","journal-title":"Clin Pharmacokinet"},{"key":"947_CR5","unstructured":"Herings R (1993) PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in The Netherlands [dissertation]. Utrecht University, Department of Pharmaco-epidemiology and -therapy, Utrecht"},{"issue":"1","key":"947_CR6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1476-5381.1993.tb13836.x","volume":"110","author":"JJ Hermans","year":"1993","unstructured":"Hermans JJ, Thijssen HH (1993) Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics. Br J Pharmacol 110(1):482\u2013490","journal-title":"Br J Pharmacol"},{"key":"947_CR7","first-page":"30","volume-title":"Oral anticoagulants","author":"AM Holbrook","year":"1996","unstructured":"Holbrook AM, Wells PS, Crowther NR (1996) Pharmacokinetics and drug interactions with warfarin. In: Poller L, Hirsch J (eds) Oral anticoagulants. Arnold, London, pp 30\u201348"},{"key":"947_CR8","unstructured":"Indiana University Department of Medicine (2003) Cytochrome P450 Drug Interaction Table [cited 2003 Feb 12]. Available from: URL: http:\/\/medicine.iupui.edu\/flockhart"},{"issue":"2","key":"947_CR9","first-page":"563","volume":"86","author":"SP Johnsen","year":"2001","unstructured":"Johnsen SP, Sorensen HT, Mellemkjoer L, Blot WJ, Nielsen GL, McLaughlin JK et al (2001) Hospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulants. Thromb Haemost 86(2):563\u2013568","journal-title":"Thromb Haemost"},{"issue":"8","key":"947_CR10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2036.2003.01550.x","volume":"17","author":"J Labenz","year":"2003","unstructured":"Labenz J, Petersen KU, Rosch W, Koelz HR (2003) A summary of food and drug administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole. Aliment Pharmacol Ther 17(8):1015\u20131019","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"947_CR11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9343(93)90285-W","volume":"95","author":"CS Landefeld","year":"1993","unstructured":"Landefeld CS, Beyth RJ (1993) Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 95(3):315\u2013328","journal-title":"Am J Med"},{"issue":"8","key":"947_CR12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.32.8.821","volume":"32","author":"X-Q Li","year":"2004","unstructured":"Li X-Q, Andersson TB, Ahlstr\u00f6m M, Weidolf L (2004) Comparison of inhibitory effects of the proton pump inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos 32(8):821\u2013827","journal-title":"Drug Metab Dispos"},{"key":"947_CR13","volume-title":"The pharmacological basis of therapeutics","author":"PW Majerus","year":"2001","unstructured":"Majerus PW, Tollefsen DM (2001) Anticoagulant, thrombolytic, and antiplatelet drugs. In: Hardman JG, Goodman Gilman A, Limbird LE (eds) The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York","edition":"10"},{"issue":"5","key":"947_CR14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00045391-200309000-00005","volume":"10","author":"DM McCarthy","year":"2003","unstructured":"McCarthy DM, McLaughlin TP, Griffis DL, Yazdani C (2003) Impact of cotherapy with some proton pump inhibitors on medical claims among HMO patients already using other common drugs also cleared by cytochrome P450. Am J Ther 10(5):330\u2013340","journal-title":"Am J Ther"},{"issue":"1","key":"947_CR15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0038-1650514","volume":"76","author":"FJ Meer van der","year":"1996","unstructured":"van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E (1996) Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thromb Haemost 76(1):12\u201316","journal-title":"Thromb Haemost"},{"issue":"9025","key":"947_CR16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","volume":"348","author":"G Palareti","year":"1996","unstructured":"Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D\u2018Angelo A et al (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 348(9025):423\u2013428","journal-title":"Lancet"},{"issue":"6","key":"947_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1067\/mcp.2001.115723","volume":"69","author":"FJA Penning-van Beest","year":"2001","unstructured":"Penning-van Beest FJA, van Meegen E, Rosendaal FR, Stricker BHCh (2001) Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther 69(6):451\u2013457","journal-title":"Clin Pharmacol Ther"},{"key":"947_CR18","volume-title":"Anticoagulants. Martindale: the extra pharmacopoeia","year":"1999","unstructured":"Reynolds JEF (ed) (1999) Anticoagulants. Martindale: the extra pharmacopoeia, 32nd edn. The Pharmaceutical Press, London","edition":"32"},{"issue":"Suppl 1","key":"947_CR19","first-page":"S31","volume":"34","author":"VW Steinijans","year":"1996","unstructured":"Steinijans VW, Huber R, Hartmann M, Zech K, Bliesath H, Wurst W et al (1996) Lack of pantoprazole drug interactions in man: an updated review. Int J Clin Pharmacol Ther 34(Suppl 1):S31\u2013S50","journal-title":"Int J Clin Pharmacol Ther"},{"key":"947_CR20","volume-title":"Drug interactions","author":"IH Stockley","year":"1996","unstructured":"Stockley IH (1996) Drug interactions, 4th edn. The Pharmaceutical Press, London","edition":"4"},{"issue":"6","key":"947_CR21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1067\/mcp.2002.124470","volume":"71","author":"LE Visser","year":"2002","unstructured":"Visser LE, Penning-van Beest FJA, Kasbergen AA, De Smet PA, Vulto AG, Hofman A et al (2002) Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants. Clin Pharmacol Ther 71(6):496\u2013502","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"947_CR22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-0037-1613289","volume":"88","author":"LE Visser","year":"2002","unstructured":"Visser LE, Penning-van Beest FJA, Kasbergen AA, De Smet PA, Vulto AG, Hofman A et al (2002) Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants. Thromb Haemost 88(5):705\u2013710","journal-title":"Thromb Haemost"},{"issue":"4","key":"947_CR23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1365-2125.2003.02036.x","volume":"57","author":"LE Visser","year":"2004","unstructured":"Visser LE, Penning-van Beest FJA, Wilson JH, Vulto AG, Kasbergen AA, De Smet PA et al (2004) Overanticoagulation associated with combined use of lactulose and coumarin anticoagulants. Br J Clin Pharmacol 57(4):522\u2013524","journal-title":"Br J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0947-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-005-0947-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0947-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T15:48:27Z","timestamp":1586274507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-005-0947-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,10]]},"references-count":23,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["947"],"URL":"https:\/\/doi.org\/10.1007\/s00228-005-0947-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,10]]}}}